Larvol Delta - Artios-Receives-US-FDA-Fast-Track-Designation-for-DNA-Polymerase-Theta-Pol-Inhibitor-ART6043-for-Treatment-of-gBRCAmutated-HER2Negative-Breast-Cancer

ART6043 - Artios Pharma

https://www.globenewswire.com/news-release/2026/02/23/3242542/0/en/Artios-Receives-U-S-FDA-Fast-Track-Designation-for-DNA-Polymerase-Theta-Pol%CE%B8-Inhibitor-ART6043-for-Treatment-of-gBRCA-mutated-HER2-Negative-Breast-Cancer.html

Feb 23, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next